Abbott (ABT) Receives FDA's Approval for the TriClip TEER System
https://www.zacks.com/stock/news/2251212/abbott-abt-receives-fda-s-approval-for-the-triclip-teer-system?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2251212
Apr 05, 2024 - Abbott (ABT) receives FDA nod for TriClip, a first-of-its-kind device to repair a leaky tricuspid heart valve.
0
Here's Why You Should Retain Penumbra (PEN) Stock for Now
https://www.zacks.com/stock/news/2252020/here-s-why-you-should-retain-penumbra-pen-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2252020
Apr 08, 2024 - Investors are optimistic about Penumbra (PEN) on strength exhibited in the Thrombectomy business and global expansion.
0
IM Cannabis (IMCC) Expands Business in Germany With New Alliance
https://www.zacks.com/stock/news/2251935/im-cannabis-imcc-expands-business-in-germany-with-new-alliance?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2251935
Apr 08, 2024 - The partnership's core objective is to grant IM Cannabis' (IMCC) subsidiary, Adjupharm GmbH, exclusive rights to introduce Avant's BLK MKT cannabis brand in Germany's medical cannabis market.
0
Silk Road Medical's (SILK) New Launch to Aid Its TCAR Portfolio
https://www.zacks.com/stock/news/2252006/silk-road-medical-s-silk-new-launch-to-aid-its-tcar-portfolio?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2252006
Apr 08, 2024 - Silk Road Medical (SILK) announces its latest launch of ENROUTE Transcarotid Neuroprotection System PLUS, which is likely to aid in TCAR procedures.
0
Why You Should Retain Inari Medical (NARI) Stock for Now
https://www.zacks.com/stock/news/2252746/why-you-should-retain-inari-medical-nari-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2252746
Apr 09, 2024 - Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.
0
Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now
https://www.zacks.com/stock/news/2252692/here-s-why-you-should-retain-myriad-genetics-mygn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2252692
Apr 09, 2024 - Investors are optimistic about Myriad Genetics' (MYGN) strong solvency position and improvement in testing volume.
0
Why You Should Retain Integer Holdings (ITGR) Stock for Now
https://www.zacks.com/stock/news/2252801/why-you-should-retain-integer-holdings-itgr-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2252801
Apr 09, 2024 - Integer Holdings' (ITGR) research and product development activities raise optimism about the stock.
0
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
https://www.zacks.com/stock/news/2253436/reasons-to-retain-fresenius-medical-fms-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2253436
Apr 10, 2024 - Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
0
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
https://www.zacks.com/stock/news/2253435/here-s-why-you-should-retain-merit-medical-mmsi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2253435
Apr 10, 2024 - Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
0
QuidelOrtho's (QDEL) New Test to Offer Enhanced Opioid Testing
https://www.zacks.com/stock/news/2254708/quidelortho-s-qdel-new-test-to-offer-enhanced-opioid-testing?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2254708
Apr 12, 2024 - QuidelOrtho's (QDEL) addition of the Fentanyl Test is likely to deliver rapid drugs-of-abuse detection amidst the escalating opioid crisis.
0